Managing multiple sclerosis (MS) through pre-conception, pregnancy and post-partum periods can be challenging, as there is limited data in this patient population. This program reviews the impact of pregnancy on MS activity, choices of DMT during pregnancy, and recommendations postpartum. The overall goal is to increase clinicians’ confidence in managing patients before, during, and after pregnancy.
This program has received an unrestricted educational grant or in-kind support from Roche.
Rola Alarieh, MSN, BSN, CNS, RN
Mona M Alkhawajah, MD
This current Expert Brief Video is part of a multi-component learning series.
This learning series is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and is approved by Queens University and accredited by the Saudi Commission for Health Specialties for up to 5.5 CPD hour(s) for the completion of all components within the series.
Upon viewing the educational video and completing requirements, participants will be better able to: